11+ hour, 24+ min ago  (557+ words) Early data showing evidence of safety, effectiveness of targeted gene therapy Written by Marisa Wexler, MS | July 9, 2026 Two major steps are now complete in an early clinical trial testing a one-time epigenetic therapy " a treatment designed to turn on or…...

4+ hour, 23+ min ago  (1287+ words) Uro Today Rashid Sayyid: Hello, everyone I'm Rashid Sayyid, Urologic Oncologist at the University of Arizona, and I'm joined today as always with Zach Klaassen, Program Director and Associate Professor of Urologic Oncology at Wellstar MCG Health in Augusta And…...

6+ hour, 48+ min ago  (486+ words) People are downing a new type of shot " and it sure packs a punch. Olive oil has taken the wellness arena by storm, with more health fanatics, biohackers and even professional athletes backing its wide range of benefits. Soccer stars…...

9+ hour, 45+ min ago  (91+ words) Purdue University researchers use VOYAGER pipettes to enhance drug discovery for non-opioid chronic pain therapies, improving assay throughput and accuracy. Scientists at Purdue University in Indiana, USA, are using VOYAGER adjustable tip spacing pipettes and PIPETBOY acu 2 serological pipet controllers…...

12+ hour, 57+ min ago  (21+ words) WXYZ Channel 7 New research shows sedentary behavior increases risk of cancer...

19+ hour, 43+ min ago  (693+ words) Major depressive disorder has been making headlines recently, but many of us don't actually know much about the condition. And that's not surprising. According to the American Psychological Association, 84 percent of Americans believe there's still a stigma surrounding mental illness....

12+ hour, 17+ min ago  (467+ words) Amsterdam, 7 July 2026 The human medicines committee (CHMP) at the European Medicines Agency (EMA) has started a phased review of data on daraxonrasib, a medicine intended for the treatment of metastatic pancreatic cancer. A phased review aims to accelerate the assessment…...

12+ hour, 44+ min ago  (875+ words) The AAV-delivered medicine is the first and only FDA-approved treatment of its kind but has raised ethical questions among those in the deaf community. Regeneron Pharmaceuticals announced in April that the US Food and Drug Administration (FDA) had granted accelerated…...

13+ hour, 59+ min ago  (517+ words) by John Pinching | 9th Jul 2026 | News The Medicines and Healthcare products Regulatory Agency has authorised Jascayd (nerandomilast) for adults with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, marking the first new IPF treatment in over a decade. The preferential PDE4 B inhibitor…...

17+ hour, 30+ min ago  (324+ words) Mirage News The CARDIO-TTRansform Phase III trial1 for Astra Zeneca and Ionis' Wainua (eplontersen) in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet the primary efficacy endpoint of the composite outcome of cardiovascular (CV) mortality and recurrent CV clinical events up…...